Dulaglutide The AWARD-7 study assessed the efficacy and safety of dulaglutide in T2D patients with moderate-to-severe CKD (Tuttle et al., 2018)
In the future, AOD 9604 is expected to become an important drug in the field of local fat reduction, providing a safer and more effective treatment option for obese patients
doi: 10.3389/fmicb.2023.1125808 Received 16 December 2022 Accepted 03 February 2023 Published 23 February 2023 Volume 14 - 2023 Edited by Huhu Wang, Nanjing Agricultural University, China Reviewed by Magdalena Olszewska, University of Warmia and Mazury in Olsztyn, Poland
Powerful Antioxidant: With its potent antioxidant properties, TAD-600 combats free radicals and oxidative stress, reducing the signs of aging such as fine lines and wrinkles
If these toxicities are not dealt with promptly and appropriately, irreversibility may ensue that can potentially lead to severe organ dysfunction (ie, colectomy) or even death